September 7, 2022 

Answers to Questions About “Updated” COVID-19 Booster Shots

After a very quick FDA approval of the new bivalent booster vaccine for COVID-19, the public still has a lot of questions about what these boosters are and why they should or should not receive one. As key vaccine providers, pharmacists are likely to be dealing with those questions on a daily basis. The FDA has provided some information to help answer them. Read more.


Taking Height Into Consideration, AFib Risk as High for Women as Men

Much of the focus on atrial fibrillation (AFib) prevention and treatment has been on men, who have a higher incidence of the cardiovascular disease than women. Find out how a new study determined that the incidence rate can be misleading when height is considered. Women are actually at greater risk than men, according to the researchers, and should be treated as aggressively.

Recent Influenza Vaccine Recommendations Changes Versus Last Year

Pharmacists should be aware of changes in public health recommendations for the upcoming influenza season. Chief among these changes is the preferential recommendation for adults aged 65 years and older to receive a higher dose of adjuvanted influenza vaccine whenever possible. Learn more about the practice recommendations published in the Morbidity & Mortality Weekly Report.


High Testosterone Levels Appear Helpful in Men With COVID-19

Earlier in the COVID-19 pandemic, when men were faring worse than women, the assumption was that testosterone was playing a role in hospitalization. A new study determined, however, that higher testosterone levels actually make it less likely that a patient will be hospitalized. Learn more about these results, published in the Journal of the American Medical Associate Network Open.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -